Status:
COMPLETED
Efficacy of a Multicomponent Cognitive Intervention in Adults With Subjective Cognitive Decline and Mild Cognitive Impairments
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Mild Cognitive Impairment
Subjective Cognitive Decline
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Individuals with mild cognitive impairment (MCI) and subjective cognitive decline (SCD) have greater risk of developing dementia. Cognitive intervention is a topic of great interest in individuals wit...
Detailed Description
This study is a pretest-posttest design. Thirty-five subjects with MCI and 35 with SCD, who are diagnosed by physicians, will be recruited from the neurology outpatient clinic of National Taiwan Unive...
Eligibility Criteria
Inclusion
- over 50 years old
- years of education \> 6
- mild cognitive impairment or subjective cognitive decline diagnosed by physician
- the Barthel Index scored 100
- the Montreal Cognitive Assessment (MoCA) \> 18
- the UPSA-Brief \> 50
Exclusion
- without concurrent major or significant psychiatric disorders
- severe physical diseases which might affect cognitive functions
- difficult to follow instructions due to visual or hearing impairments
Key Trial Info
Start Date :
January 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2021
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04023032
Start Date
January 2 2019
End Date
August 29 2021
Last Update
September 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan